Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

17.74
-0.0600-0.34%
Post-market: 17.800.0600+0.34%19:30 EDT
Volume:28.78K
Turnover:509.79K
Market Cap:104.67M
PE:- -
High:17.93
Open:17.89
Low:17.60
Close:17.80
52wk High:21.50
52wk Low:14.38
Shares:5.90M
Float Shares:5.90M
Volume Ratio:0.55
T/O Rate:0.49%
Dividend:0.71
Dividend Rate:4.03%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Wuxi Biologics (Cayman) Stock Rallies 2.7% in Hong Kong

Dow Jones
·
Aug 21

CSPC Pharmaceutical Group Stock Falls 3.5% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 21

美银证券上调石药集团目标价至8.6港元,维持“跑输大市”评级

Stock News
·
Aug 21

Akeso Says China NMPA Clears Phase I Trial for B7-H3 ADC Ak157d1 in Solid Tumors

Reuters
·
Aug 21

Akeso's Ak157d1 (B7-H3 ADC) Cleared for Phase I Trial in Solid Tumors, Adding a Third Differentiated ADC to Its Pipeline

THOMSON REUTERS
·
Aug 21

Morgan Stanley Raises CSPC Pharma Target Price to HK$12, Maintains Overweight Rating

Stock News
·
Aug 21

Moderna's Personalized mRNA Vaccine Achieves First Success, Chinese Innovators Line Up

Deep News
·
Aug 21

China's Simcere Pharmaceutical H1 Revenue Rises on Neuroscience, Autoimmune Drugs Strength

Reuters
·
Aug 20

Pharma Sector Doubles Down on AI Amid Hopes of Slashing Costs, Timelines

Reuters
·
Aug 20

Southbound Capital Daily: Net Selloff Hits HK$10.41B, Alibaba Draws Mainland Buying Pre-Earnings, Healthcare Stocks Split

Stock News
·
Aug 20

Hong Kong Stocks Rise on Thursday on Easing Bond Concerns, Tech Gains; CSPC Pharma Jumps 9%

MT Newswires Live
·
Aug 20

CSPC Pharma Surges 15% as Moderna's mRNA Cancer Vaccine Hits Key Milestone

Stock News
·
Aug 20

Norway's Vistin Pharma Q2 Revenue Falls on Currency Impact

Reuters
·
Aug 20

CSPC Pharma (01093) Surges Over 12% After Interim Profit Jumps Nearly 1.4-Fold

Stock News
·
Aug 20

CSPC Pharmaceutical Hits 6-Month High on Profit, Dividend Surge

Reuters
·
Aug 20

CSPC Pharmaceutical's Attributable Profit More Than Doubles in H1; Shares Jump 14%

MT Newswires Live
·
Aug 20

CSPC Pharma FY26 H1 Profit Attributable to Shareholders More than Doubled to RMB 6.09 Billion; Revenue Rises 40.1% to RMB 18.59 Billion

Reuters
·
Aug 20

CSPC Pharmaceutical Group H1 Net Income Attributable RMB 6,094.2 Million

THOMSON REUTERS
·
Aug 20

CSPC Pharmaceutical Group - Interim Dividend of HK18 Cents Per Share for 2026

THOMSON REUTERS
·
Aug 20

Biotech Sector Surges as Moderna's Melanoma Vaccine Milestone Sparks Oncology and mRNA Repricing

Stock News
·
Aug 20